4Filing Date: Sep 14, 2026

Guardant Health (GH)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001927831-26-000022
Total Value$632.2K
Trades1
Insiders1

Transaction Details

Kalia Kumud
Chief Information Officer·Direct
Sell · Dispose
Common Stock
Shares-4.00K
Price$158.05
Total Value$632.2K
Shares Owned After39.79K
Transaction DateSep 11, 2026
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $157.99 to $158.215. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Post-Transaction Holdings

Kalia Kumud · Chief Information Officer
SecuritySharesChange
Common Stock39.79K-4.00K (-9.13%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-11 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Kalia Kumud CIK: 0001927831 Role: Officer (Chief Information Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-11 | Code: S (Open market sale) Shares: -4,000 | Price: $158.05 Total Value: $632,193.20 Shares Owned After: 39,794 | Ownership: D (Direct) Footnotes: [F1] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $157.99 to $158.215. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. --- Footnotes (Complete Index) --- F1: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $157.99 to $158.215. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. --- Signature --- /s/ /s/ John G. Saia, as attorney-in-fact for Kumud Kalia (2026-09-14)

keid analysis is for reference only and does not constitute investment advice.